Structures by: Ouzidan Y.
Total: 54
6-Bromo-2-(4-chlorophenyl)-3-[(1-octyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C23H26BrClN6
IUCrData (2019) 4, 1 x190053
a=16.252(3)Å b=5.3787(9)Å c=27.109(4)Å
α=90° β=90.551(12)° γ=90°
7-Bromo-1,4-bis(prop-2-ynyl)pyrido[2,3-<i>b</i>]pyrazine-2,3(1<i>H</i>,4<i>H</i>)-dione
C13H8BrN3O2
IUCrData (2018) 3, 2 x180266
a=10.1922(5)Å b=17.3470(10)Å c=7.0216(4)Å
α=90° β=92.382(5)° γ=90°
(Pyridin-2-yl)methyl 6-bromo-2-oxo-1-[(pyridin-2-yl)methyl]-1,2-dihydroquinoline-4-carboxylate
C22H16BrN3O3
IUCrData (2018) 3, 2 x180288
a=34.0146(11)Å b=4.9522(2)Å c=23.4539(7)Å
α=90° β=111.5780(10)° γ=90°
Ethyl (2<i>E</i>)-3-dimethylamino-2-(5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)prop-2-enoate
C13H17N5O2
IUCrData (2016) 1, 12 x161946
a=7.1482(15)Å b=10.306(2)Å c=19.705(4)Å
α=90° β=99.711(3)° γ=90°
<i>N</i>-{2-[2-(5-Methyl-1<i>H</i>-pyrazol-3-yl)acetamido]phenyl}benzamide monohydrate
C19H18N4O2,H2O
IUCrData (2017) 2, 2 x170251
a=8.4220(3)Å b=10.0410(4)Å c=10.8799(4)Å
α=101.889(2)° β=94.104(2)° γ=90.4020(10)°
<i>trans</i>-Bis(<i>N</i>-{2-[2-(3-methyl-1<i>H</i>-pyrazol-5-yl-κ<i>N</i>^2^)acetamido-κ<i>O</i>]phenyl}benzamide)bis(perchlorato-κ<i>O</i>)copper(II)
C38H36Cl2CuN8O12
IUCrData (2017) 2, 2 x170285
a=8.6572(2)Å b=8.8108(2)Å c=14.2054(3)Å
α=79.4060(10)° β=86.2400(10)° γ=67.8950(10)°
4-Methyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C9H9NOS
IUCrData (2017) 2, 2 x170097
a=7.3148(6)Å b=8.4030(6)Å c=27.670(2)Å
α=90° β=90° γ=90°
5-Fluoro-1-(prop-2-en-1-yl)-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C11H8FNO2
IUCrData (2017) 2, 1 x170028
a=31.531(3)Å b=4.2752(4)Å c=14.1080(13)Å
α=90° β=90° γ=90°
6-Bromo-2-(4-chlorophenyl)-3-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C13H9BrClN3
IUCrData (2016) 1, 5 x160763
a=12.1163(2)Å b=9.7911(2)Å c=20.9428(4)Å
α=90° β=90° γ=90°
Ethyl 2-(6-bromo-2-phenyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)acetate
C16H14BrN3O2
IUCrData (2016) 1, 5 x160771
a=14.6923(8)Å b=6.1988(3)Å c=16.2254(8)Å
α=90° β=92.9110(10)° γ=90°
(2<i>Z</i>)-4-Benzyl-[(4-chlorophenyl)methylidene]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C22H16ClNOS
IUCrData (2016) 1, 5 x160764
a=11.8931(11)Å b=6.5358(6)Å c=22.817(2)Å
α=90° β=93.2390(10)° γ=90°
2-[(2<i>Z</i>)-2-Benzylidene-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl]acetic acid
C17H13NO3S
IUCrData (2016) 1, 6 x160863
a=8.6760(3)Å b=8.7882(3)Å c=9.8142(4)Å
α=78.2000(10)° β=73.3110(10)° γ=86.2420(10)°
(4<i>Z</i>)-1-Benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C19H18N2O2
IUCrData (2016) 1, 9 x161448
a=8.2829(2)Å b=13.8636(4)Å c=15.1292(4)Å
α=72.3280(10)° β=74.9220(10)° γ=87.2520(10)°
6-Chloro-1,4-diethylquinoxaline-2,3(1<i>H</i>,4<i>H</i>)-dione
C12H13ClN2O2
IUCrData (2017) 2, 7 x171052
a=14.6454(8)Å b=12.0415(5)Å c=15.1149(9)Å
α=90° β=115.621(7)° γ=90°
4-{[5-Methyl-2-(propan-2-yl)phenoxy]methyl}-1-(4-nitrobenzyl)-1<i>H</i>-1,2,3-triazole
C20H22N4O3
IUCrData (2017) 2, 4 x170516
a=9.4118(3)Å b=10.8934(4)Å c=18.6996(7)Å
α=101.6290(10)° β=91.7520(10)° γ=90.3510(10)°
5,6-Dimethyl-2-[(5-methyl-1,2-oxazol-3-yl)methyl]-1-(prop-2-en-1-yl)-1<i>H</i>-1,3-benzodiazole
C17H19N3O
IUCrData (2017) 2, 7 x170647
a=19.6067(6)Å b=5.5438(2)Å c=14.0069(5)Å
α=90° β=99.911(2)° γ=90°
(<i>Z</i>)-2-Benzylidene-3-<i>n</i>-butoxy-2<i>H</i>-1,4-benzothiazine
C19H19NOS
IUCrData (2017) 2, 6 x170890
a=7.7711(6)Å b=10.9897(11)Å c=11.4090(11)Å
α=112.013(9)° β=109.259(8)° γ=98.120(7)°
(<i>Z</i>)-4-<i>n</i>-Butyl-2-(4-chlorobenzylidene)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C19H18ClNOS
IUCrData (2017) 2, 6 x170870
a=8.8898(8)Å b=8.9885(9)Å c=12.1973(10)Å
α=89.908(8)° β=84.490(7)° γ=63.534(9)°
1,4-Dibenzyl-6-chloroquinoxaline-2,3(1<i>H</i>,4<i>H</i>)-dione
C22H17ClN2O2
IUCrData (2017) 2, 6 x170901
a=29.2234(4)Å b=8.3076(2)Å c=31.0407(5)Å
α=90° β=101.859(2)° γ=90°
4-[(1<i>H</i>-Imidazol-1-yl)methyl]-1-(4-nitrobenzyl)-1<i>H</i>-1,2,3-triazole
C13H12N6O2
IUCrData (2017) 2, 4 x170515
a=20.3330(4)Å b=14.2764(3)Å c=4.50890(10)Å
α=90° β=90° γ=90°
(Pyridin-2-yl)methyl 2-oxo-1-[(pyridin-2-yl)methyl]-1,2-dihydroquinoline-4-carboxylate hemihydrate
C22H17N3O3,0.5(H2O)
IUCrData (2017) 2, 7 x171038
a=4.96340(10)Å b=14.0708(3)Å c=25.7168(6)Å
α=90° β=90.6020(10)° γ=90°
7-Bromo-1,4-dibutyl-1,2,3,4-tetrahydropyrido[2,3-<i>b</i>]pyrazine-2,3-dione
C15H20BrN3O2
IUCrData (2017) 2, 7 x170984
a=22.569(6)Å b=5.1097(13)Å c=13.497(3)Å
α=90° β=90° γ=90°
Prop-2-ynyl 2-oxo-1-(prop-2-ynyl)-1,2-dihydroquinoline-4-carboxylate
C16H11NO3
IUCrData (2017) 2, 7 x171072
a=7.3070(11)Å b=8.7763(13)Å c=11.2927(13)Å
α=91.059(11)° β=107.867(12)° γ=109.814(14)°
(<i>Z</i>)-2-(2-Chlorobenzylidene)-4-(prop-2-ynyl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C18H12ClNOS
IUCrData (2017) 2, 6 x170889
a=13.3937(8)Å b=8.9106(4)Å c=13.3940(7)Å
α=90° β=99.765(5)° γ=90°
4-Benzyl-6-bromo-2-(4-chlorophenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C19H13BrClN3
IUCrData (2017) 2, 6 x170899
a=8.7749(7)Å b=9.9403(7)Å c=10.4475(8)Å
α=76.030(6)° β=66.511(7)° γ=85.843(6)°
2-Oxo-1,2-dihydroquinoline-4-carboxylic acid monohydrate
C10H7NO3,H2O
IUCrData (2016) 1, 6 x160997
a=20.7884(8)Å b=3.72150(10)Å c=23.8849(9)Å
α=90° β=98.582(2)° γ=90°
7-Bromo-2,3-bis[(prop-2-yn-1-yl)sulfanyl]pyrido[2,3-<i>b</i>]pyrazine
C13H8BrN3S2
IUCrData (2016) 1, 11 x161881
a=4.21590(10)Å b=16.7730(5)Å c=19.4656(5)Å
α=90° β=91.1490(10)° γ=90°
(2<i>Z</i>)-2-Benzylidene-4-[(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C25H20N4OS
IUCrData (2016) 1, 11 x161823
a=21.8833(8)Å b=5.7007(2)Å c=16.8054(6)Å
α=90° β=100.2340(10)° γ=90°
Ethyl 2-{6-bromo-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl}acetate
C16H14BrN3O2
IUCrData (2016) 1, 12 x161999
a=21.1444(14)Å b=7.6970(5)Å c=21.2671(14)Å
α=90° β=118.0730(10)° γ=90°
1,4-Dibenzyl-6-methyl-1,4-dihydroquinoxaline-2,3-dione
C23H20N2O2
Acta Crystallographica Section E (2020) 76, 8 1361-1364
a=9.0844(12)Å b=18.7227(18)Å c=11.2708(14)Å
α=90° β=104.848(4)° γ=90°
1,4,6-Trimethylquinoxaline-2,3(1<i>H</i>,4<i>H</i>)-dione monohydrate
C11H12N2O2,H2O
Acta Crystallographica Section E (2020) 76, 8 1296-1301
a=7.0695(4)Å b=10.8321(5)Å c=14.4349(6)Å
α=90° β=101.556(3)° γ=90°
(2<i>Z</i>)-2-(4-Fluorobenzylidene)-4-(prop-2-yn-1-yl)-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C18H12FNOS
Acta Crystallographica Section E (2019) 75, 3 372-377
a=4.0602(2)Å b=13.8983(5)Å c=14.2620(5)Å
α=117.809(2)° β=93.155(2)° γ=94.416(2)°
(<i>Z</i>)-Ethyl 2-{5-[(2-benzylidene-3-oxo-2,3-dihydrobenzo[<i>b</i>][1,4]thiazin-4-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C22H20N4O3S
Acta Crystallographica Section E (2015) 71, 12 o1022-o1023
a=9.9767(6)Å b=8.7342(5)Å c=23.1027(14)Å
α=90° β=94.5080(10)° γ=90°
4-Benzyl-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C15H13NOS
Acta Crystallographica Section E (2015) 71, 12 o999
a=10.8711(7)Å b=5.3815(3)Å c=21.1997(13)Å
α=90° β=93.1280(10)° γ=90°
5-Chloro-1,3-bis[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C17H19ClN4O5
Acta Crystallographica Section E (2015) 71, 10 o735-o736
a=14.053(8)Å b=13.438(6)Å c=9.733(4)Å
α=90° β=90° γ=90°
3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-6-bromo-2-phenyl- 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C22H17BrN6
Acta Crystallographica Section E (2011) 67, 4 o890-o891
a=41.122(6)Å b=5.8358(10)Å c=15.988(3)Å
α=90° β=93.922(6)° γ=90°
5-Nitro-1-nonyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C16H23N3O3
Acta Crystallographica Section E (2011) 67, 3 o669
a=5.4830(10)Å b=10.2092(15)Å c=14.746(3)Å
α=74.275(9)° β=79.727(6)° γ=83.410(8)°
1-Nonyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C16H24N2O
Acta Crystallographica Section E (2011) 67, 2 o283
a=18.0230(10)Å b=5.4585(2)Å c=16.5708(9)Å
α=90.00° β=115.543(7)° γ=90.00°
1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-1<i>H</i>-benzimidazol- 2(3<i>H</i>)-one
C17H20N4O5
Acta Crystallographica Section E (2011) 67, 2 o362-o363
a=10.5331(10)Å b=10.9647(10)Å c=14.5541(14)Å
α=90° β=103.258(5)° γ=90°
4-Benzyl-6-bromo-2-phenyl-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C19H14BrN3
Acta Crystallographica Section E (2010) 66, 4 o946
a=8.6613(6)Å b=19.7631(13)Å c=9.3683(6)Å
α=90.00° β=99.647(3)° γ=90.00°
4-Benzyl-6-bromo-2-(4-methoxyphenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine monohydrate
C20H16BrN3O,H2O
Acta Crystallographica Section E (2010) 66, 4 o947
a=10.5924(2)Å b=5.45440(10)Å c=31.7444(7)Å
α=90.00° β=100.2920(10)° γ=90.00°
3-Benzyl-6-bromo-2-(2-furyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C17H12BrN3O
Acta Crystallographica Section E (2010) 66, 7 o1874
a=15.8422(3)Å b=5.47470(10)Å c=18.4243(3)Å
α=90.00° β=111.5090(10)° γ=90.00°
4-Allyl-6-bromo-2-phenyl-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine monohydrate
C15H12BrN3,H2O
Acta Crystallographica Section E (2010) 66, 8 o1903
a=7.43630(10)Å b=9.42380(10)Å c=11.0829(2)Å
α=68.0760(10)° β=74.6370(10)° γ=79.7360(10)°
1,3-Diallyl-5-chloro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C13H13ClN2O
Acta Crystallographica Section E (2011) 67, 2 o520
a=7.88310(10)Å b=15.2481(3)Å c=10.3593(2)Å
α=90.00° β=93.0560(10)° γ=90.00°
5-Nitro-1-<i>n</i>-octyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C15H21N3O3
Acta Crystallographica Section E (2011) 67, 3 o558
a=4.9997(3)Å b=11.4942(6)Å c=13.8739(7)Å
α=74.214(3)° β=79.637(4)° γ=84.108(4)°
1-<i>n</i>-decyl-5-nitro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C17H25N3O3
Acta Crystallographica Section E (2011) 67, 3 o613
a=5.4933(2)Å b=10.3063(4)Å c=16.1655(6)Å
α=106.504(2)° β=98.545(2)° γ=96.809(2)°
1,3-Bis(prop-2-ynyl)-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one
C13H10N2O
Acta Crystallographica Section E (2011) 67, 5 o1091
a=7.7398(4)Å b=17.1869(9)Å c=8.4856(5)Å
α=90.00° β=101.459(6)° γ=90.00°
3-[2-(6-Bromo-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin- 3-yl)ethyl]-1,3-oxazolidin-2-one
C17H15BrN4O2
Acta Crystallographica Section E (2011) 67, 5 o1095
a=11.3553(6)Å b=11.5915(5)Å c=12.2542(8)Å
α=90.00° β=98.685(6)° γ=90.00°
1-Decyl-6-nitro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C17H25N3O3
Acta Crystallographica Section E (2011) 67, 11 o2937
a=32.9827(6)Å b=4.55881(9)Å c=29.3435(5)Å
α=90.00° β=109.481(2)° γ=90.00°
6-Bromo-3-methyl-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C13H10BrN3
Acta Crystallographica Section E (2011) 67, 7 o1684
a=13.7138(4)Å b=6.7088(2)Å c=25.3217(7)Å
α=90.00° β=90.00° γ=90.00°
1-(Prop-2-ynyl)-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C10H8N2O
Acta Crystallographica Section E (2013) 69, 1 o119
a=4.5553(6)Å b=18.001(3)Å c=10.7488(13)Å
α=90.00° β=93.645(8)° γ=90.00°
1-Benzyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C14H12N2O
Acta Crystallographica Section E (2011) 67, 7 o1822
a=13.8652(7)Å b=5.7975(3)Å c=14.9337(7)Å
α=90.00° β=109.5346(12)° γ=90.00°
5-Nitro-1-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C10H7N3O3
Acta Crystallographica Section E (2012) 68, 4 o1240
a=7.2541(2)Å b=10.0362(2)Å c=14.6793(3)Å
α=100.9780(10)° β=92.0470(10)° γ=109.0430(10)°
1-Allyl-5-nitro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C10H9N3O3
Acta Crystallographica Section E (2013) 69, 3 o431
a=8.3246(3)Å b=14.9567(6)Å c=16.4461(7)Å
α=90.00° β=90.00° γ=90.00°